ClinicalTrials.gov
ClinicalTrials.gov Menu

Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00425646
Recruitment Status : Completed
First Posted : January 23, 2007
Last Update Posted : May 6, 2013
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
University of Washington

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2007
  Actual Study Completion Date : July 2009